Literature DB >> 12429823

Cotranslational partitioning of nascent prion protein into multiple populations at the translocation channel.

Soo Jung Kim1, Ramanujan S Hegde.   

Abstract

The decisive events that direct a single polypeptide such as the prion protein (PrP) to be synthesized at the endoplasmic reticulum in both fully translocated and transmembrane forms are poorly understood. In this study, we demonstrate that the topological heterogeneity of PrP is determined cotranslationally, while at the translocation channel. By evaluating sequential intermediates during PrP topogenesis, we find that signal sequence-mediated initiation of translocation results in an interaction between nascent PrP and endoplasmic reticulum chaperones, committing the N terminus to the lumen. Synthesis of the transmembrane domain before completion of this step allows it to direct the generation of (Ctm)PrP, a transmembrane form with its N terminus in the cytosol. Thus, segregation of nascent PrP into different topological configurations is critically dependent on the precise timing of signal-mediated initiation of N-terminus translocation. Consequently, this step could be experimentally tuned to modify PrP topogenesis, including complete reversal of the elevated (Ctm)PrP caused by disease-associated mutations in the transmembrane domain. These results delineate the sequence of events involved in PrP biogenesis, explain the mechanism of action of (Ctm)PrP-favoring mutations associated with neurodegenerative disease, and more generally, reveal that translocation substrates can be cotranslationally partitioned into multiple populations at the translocon.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429823      PMCID: PMC133591          DOI: 10.1091/mbc.e02-05-0293

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  39 in total

1.  A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum.

Authors:  R S Stewart; B Drisaldi; D A Harris
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

2.  Regulation of ribosome detachment from the mammalian endoplasmic reticulum membrane.

Authors:  M D Potter; C V Nicchitta
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

Review 3.  Topogenesis of membrane proteins: determinants and dynamics.

Authors:  V Goder; M Spiess
Journal:  FEBS Lett       Date:  2001-08-31       Impact factor: 4.124

4.  Substrate-specific regulation of the ribosome- translocon junction by N-terminal signal sequences.

Authors:  D T Rutkowski; V R Lingappa; R S Hegde
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

5.  Combinatorial control of prion protein biogenesis by the signal sequence and transmembrane domain.

Authors:  S J Kim; R Rahbar; R S Hegde
Journal:  J Biol Chem       Date:  2001-05-18       Impact factor: 5.157

6.  Prion protein contains a second endoplasmic reticulum targeting signal sequence located at its C terminus.

Authors:  C Hölscher; U C Bach; B Dobberstein
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

7.  Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein.

Authors:  C S Yost; C D Lopez; S B Prusiner; R M Myers; V R Lingappa
Journal:  Nature       Date:  1990-02-15       Impact factor: 49.962

8.  Transmissible and genetic prion diseases share a common pathway of neurodegeneration.

Authors:  R S Hegde; P Tremblay; D Groth; S J DeArmond; S B Prusiner; V R Lingappa
Journal:  Nature       Date:  1999-12-16       Impact factor: 49.962

9.  Most pathogenic mutations do not alter the membrane topology of the prion protein.

Authors:  R S Stewart; D A Harris
Journal:  J Biol Chem       Date:  2000-10-25       Impact factor: 5.157

Review 10.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

View more
  34 in total

1.  Protection from cytosolic prion protein toxicity by modulation of protein translocation.

Authors:  Neena S Rane; Jesse L Yonkovich; Ramanujan S Hegde
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

2.  Transmembrane protein topology mapping by the substituted cysteine accessibility method (SCAM(TM)): application to lipid-specific membrane protein topogenesis.

Authors:  Mikhail Bogdanov; Wei Zhang; Jun Xie; William Dowhan
Journal:  Methods       Date:  2005-06       Impact factor: 3.608

3.  Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway.

Authors:  Sang-Wook Kang; Neena S Rane; Soo Jung Kim; Jennifer L Garrison; Jack Taunton; Ramanujan S Hegde
Journal:  Cell       Date:  2006-12-01       Impact factor: 41.582

4.  Reduced translocation of nascent prion protein during ER stress contributes to neurodegeneration.

Authors:  Neena S Rane; Sang-Wook Kang; Oishee Chakrabarti; Lionel Feigenbaum; Ramanujan S Hegde
Journal:  Dev Cell       Date:  2008-09       Impact factor: 12.270

Review 5.  Lysosomal Quality Control in Prion Diseases.

Authors:  Priyanka Majumder; Oishee Chakrabarti
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

6.  Failure of prion protein oxidative folding guides the formation of toxic transmembrane forms.

Authors:  Silvia Lisa; Beatriz Domingo; Javier Martínez; Sabine Gilch; Juan F Llopis; Hermann M Schätzl; María Gasset
Journal:  J Biol Chem       Date:  2012-09-06       Impact factor: 5.157

Review 7.  The consequences of pathogenic mutations to the human prion protein.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2009-07-14       Impact factor: 1.650

Review 8.  Prion protein biosynthesis and its emerging role in neurodegeneration.

Authors:  Oishee Chakrabarti; Aarthi Ashok; Ramanujan S Hegde
Journal:  Trends Biochem Sci       Date:  2009-05-15       Impact factor: 13.807

9.  Signal sequence insufficiency contributes to neurodegeneration caused by transmembrane prion protein.

Authors:  Neena S Rane; Oishee Chakrabarti; Lionel Feigenbaum; Ramanujan S Hegde
Journal:  J Cell Biol       Date:  2010-02-15       Impact factor: 10.539

10.  Cell type-specific neuroprotective activity of untranslocated prion protein.

Authors:  Elena Restelli; Luana Fioriti; Susanna Mantovani; Simona Airaghi; Gianluigi Forloni; Roberto Chiesa
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.